Jie Lu

  • Lab Manager

Education & Training

  • BA, Hunan Medical School, China

Selected Publications

1, Inhibition of Hepatocellular Carcinoma by Metabolic Normalization Wang H, Lu J, Dolezal J, Kulkarni S, Zhang W, Chen A, Gorka J, Mandel JA,Prochownik EV. PLoS One. 2019 Jun 26;14(6):e0218186. doi: 10.1371/journal.pone.0218186. eCollection 2019. PMID: 31242205
2, β-CateninMutations as Determinants of Hepatoblastoma Phenotypes in Mice Zhang W, Meyfeldt J, Wang H, Kulkarni S, Lu J, Mandel JA, Marburger B, Liu Y,Gorka JE, Ranganathan S, Prochownik EV. J Biol Chem. 2019 Nov 15;294(46):17524-17542. doi: 10.1074/jbc.RA119.009979. Epub 2019 Oct 9. PMID:31597698
3, Metabolic and Oncogenic Adaptations to Pyruvate Dehydrogenase Inactivation in Fibroblasts Wang H, Lu J, Kulkarni S, Zhang W, GorkaJE, Mandel JA, Goetzman ES, Prochownik EV. J Biol Chem. 2019 Apr 5;294(14):5466-5486. doi: 10.1074/jbc.RA118.005200. Epub 2019 Feb 12. PMID:30755479
4, Myc and ChREBP Transcription Factors Cooperatively Regulate Normal and Neoplastic Hepatocyte Proliferation in Mice Wang H, DolezalJM, Kulkarni S, Lu J, Mandel J, Jackson LE, Alencastro F, Duncan AW, Prochownik EV. J Biol Chem. 2018 Sep 21;293(38):14740-14757. doi:10.1074/jbc.RA118.004099. Epub 2018 Aug 7. PMID: 30087120
5, Ribosomopathy-like Properties of Murine and Human Cancers Kulkarni S, DolezalJM, Wang H, Jackson L, Lu J, Frodey BP, Dosunmu-Ogunbi A, Li Y, Fromherz M, Kang A, Santana-Santos L, Benos PV, Prochownik EV. PLoS One.2017 Aug 18;12(8):e0182705. doi: 10.1371/journal.pone.0182705. eCollection 2017. PMID: 28820908
6, Sequential Adaptive Changes in a c-Myc-drivenModel of Hepatocellular Carcinoma Dolezal JM, Wang H, Kulkarni S, Jackson L, Lu J, Ranganathan S, Goetzman ES, Bharathi SS, Beezhold K,Byersdorfer CA, Prochownik EV. J Biol Chem. 2017 Jun 16;292(24):10068-10086. doi: 10.1074/jbc.M117.782052. Epub 2017 Apr 21. PMID: 28432125

Research Interest Summary

Liver Cancer